Advertisement
U.S. markets closed

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
21.63+0.47 (+2.22%)
At close: 04:00PM EDT
21.63 0.00 (0.00%)
After hours: 05:39PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close21.16
Open21.07
Bid16.00 x 800
Ask28.01 x 900
Day's Range20.99 - 21.71
52 Week Range13.82 - 24.21
Volume480,245
Avg. Volume651,563
Market Cap1.944B
Beta (5Y Monthly)1.96
PE Ratio (TTM)N/A
EPS (TTM)-3.18
Earnings DateMay 01, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.36
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MYGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Myriad Genetics, Inc.
    MYGN: Lowering target price to $19.00MYRIAD GENETICS INC has an Investment Rating of SELL; a target price of $19.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more